The results of our study illustrated novel insights into the regulation of endometrial carcinoma progression mediated by lncRNAs and IGF2BP3, which highlighted the value of IGF2BP3 combined with LINC00958 as predictors for prognosis and therapeutic candidates in EC. Here, IGF2BP3 is linked to endometrial carcinoma.